thiazoles has been researched along with sudoxicam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX | 1 |
Kalgutkar, AS; Obach, RS; Ryder, TF; Walker, GS | 1 |
Barnette, DA; Flynn, N; Matlock, M; Miller, GP; Osborn, LR; Schleiff, MA; Swamidass, SJ | 1 |
3 other study(ies) available for thiazoles and sudoxicam
Article | Year |
---|---|
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles | 2008 |
In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam.
Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Hepatocytes; Humans; Ketones; Meloxicam; Microsomes, Liver; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Thiazines; Thiazoles | 2008 |
Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
Topics: Activation, Metabolic; Biotransformation; Chemical and Drug Induced Liver Injury; Electrons; Epoxy Compounds; Humans; Hydroxylation; In Vitro Techniques; Kinetics; Meloxicam; Metabolic Networks and Pathways; Microsomes, Liver; Thiazines; Thiazoles | 2020 |